We also performed a sensitivity analysis that excluded from the “High” Group the genes that were significantly (or borderline) associated with BC in our population (i.e., ATM, CHEK2, PALB2, FANCM, MAST1) to test whether the differential effect was driven by those genes. This evidence concerns the gene FANCM and breast cancer.